Pro: "Antidote for new anticoagulants"--specific target of inhibition requires a specific target for neutralisation.
Hematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain. vroldans@gmail.com
Vanessa
V
Roldán
Francisco
F
Marín
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects* / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics; D000931:Antidotes / Q000008:administration & dosage / Q000494:pharmacology; D001779:Blood Coagulation Factors / Q000008:administration & dosage; D006207:Half-Life; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D006435:Renal Dialysis; D014812:Vitamin K / Q000008:administration & dosage
D000925:Anticoagulants; D000931:Antidotes; D001779:Blood Coagulation Factors; D014812:Vitamin K; C025667:prothrombin complex concentrates